MiMedx Group, Inc. (MDXG)Healthcare | Biotechnology | Marietta, United States | NasdaqCM
3.42 USD
-0.02
(-0.437%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 3.41 0.00 (-0.005%) ⇩ (April 17, 2026, 7:01 p.m. EDT) Short-term: ★★★☆☆ | Long-term: ★★★☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 3:34 p.m. EDT
MDXG shows a mixed outlook. The recent pullback and lower price relative to the 52-week high suggest potential for a rebound, but the high short ratio and short percent of float indicate some bearish sentiment. The options activity shows a concentration around the $5.00 strike, indicating potential for significant price movement. While the company has a solid revenue growth and positive analyst recommendations, the lack of dividends and the current price being below the 52-week low make it a speculative play rather than a safe investment. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.155154 |
| AutoTheta | 0.156898 |
| AutoETS | 0.159202 |
| AutoARIMA | 0.159291 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 40% |
| H-stat | 107.86 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.183 |
| Excess Kurtosis | -1.27 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 8.783 |
| Revenue per Share | 2.833 |
| Market Cap | 507,354,912 |
| Trailing P/E | 10.67 |
| Forward P/E | 18.46 |
| Beta | 1.65 |
| Profit Margins | 11.60% |
| Website | https://www.mimedx.com |
As of April 11, 2026, 3:34 p.m. EDT: The options activity indicates mixed sentiment. Calls and puts show a concentration around the $5.00 strike, which is currently the ATM anchor. The high open interest and implied volatility suggest that traders are anticipating significant price movement, either upwards or downwards. The recent pullback and the current price being below the 52-week low may indicate potential for a rebound, but the high short ratio and short percent of float suggest some bearish sentiment. Overall, the options data signals a cautious outlook with potential for volatility.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.47633588 |
| Address1 | 1,775 West Oak Commons Court, NE |
| All Time High | 18.25 |
| All Time Low | 0.35 |
| Ask | 3.46 |
| Ask Size | 2 |
| Audit Risk | 6 |
| Average Analyst Rating | 1.2 - Strong Buy |
| Average Daily Volume10 Day | 1,430,110 |
| Average Daily Volume3 Month | 1,094,914 |
| Average Volume | 1,094,914 |
| Average Volume10Days | 1,430,110 |
| Beta | 1.65 |
| Bid | 3.37 |
| Bid Size | 2 |
| Board Risk | 2 |
| Book Value | 1.732 |
| City | Marietta |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 2 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.415 |
| Current Ratio | 4.318 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 3.6 |
| Day Low | 3.385 |
| Debt To Equity | 8.783 |
| Display Name | MiMedx |
| Earnings Call Timestamp End | 1,772,055,000 |
| Earnings Call Timestamp Start | 1,772,055,000 |
| Earnings Growth | 0.995 |
| Earnings Quarterly Growth | 1.042 |
| Earnings Timestamp | 1,772,053,200 |
| Earnings Timestamp End | 1,777,492,800 |
| Earnings Timestamp Start | 1,777,492,800 |
| Ebitda | 78,768,000 |
| Ebitda Margins | 0.18816 |
| Enterprise To Ebitda | 4.618 |
| Enterprise To Revenue | 0.869 |
| Enterprise Value | 363,765,888 |
| Eps Current Year | 0.0425 |
| Eps Forward | 0.185 |
| Eps Trailing Twelve Months | 0.32 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 4.5136 |
| Fifty Day Average Change | -1.0985999 |
| Fifty Day Average Change Percent | -0.24339771 |
| Fifty Two Week Change Percent | -47.633587 |
| Fifty Two Week High | 7.99 |
| Fifty Two Week High Change | -4.575 |
| Fifty Two Week High Change Percent | -0.5725907 |
| Fifty Two Week Low | 3.31 |
| Fifty Two Week Low Change | 0.10500002 |
| Fifty Two Week Low Change Percent | 0.03172206 |
| Fifty Two Week Range | 3.31 - 7.99 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,202,826,600,000 |
| Float Shares | 117,608,281 |
| Forward Eps | 0.185 |
| Forward P E | 18.45946 |
| Free Cashflow | 63,337,000 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 808 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.82558995 |
| Gross Profits | 345,616,992 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.02339 |
| Held Percent Institutions | 0.73579 |
| Implied Shares Outstanding | 148,566,586 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,207,094,400 |
| Last Split Factor | 3,235:10000 |
| Long Business Summary | MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. The company's wound care products include EPIFIX, EPICORD, EPIXPRESS, CHORIOFIX, EMERGE, CELERA, REGENKIT WOUND GEL, and EPIEFFECT sheets for use as protective barriers that enables a healthcare provider to select an appropriate size graft based on the size of the wound to reduce product waste. Its surgical and other product offerings consist of AMNIOFIX, AMNIOBURN, AMNIOCORD, AXIOFILL, HELIOGEN, and AMNIOEFFECT for applications in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery, and various orthopedic repairs and reconstructions. The company's products are used in the areas of wound care, burn, and surgical fields in healthcare. It sells its products through direct sales force and independent sales agents, as well as to individual customers and independent distributors in the United States. The company has a strategic alliance with Vaporox, Inc. for the promotion of their wound care offerings. The company was founded in 2006 and is headquartered in Marietta, Georgia. |
| Long Name | MiMedx Group, Inc. |
| Market | us_market |
| Market Cap | 507,354,912 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_35961030 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | 48,578,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 507,354,891 |
| Number Of Analyst Opinions | 5 |
| Open | 3.49 |
| Operating Cashflow | 74,003,000 |
| Operating Margins | 0.17847 |
| Overall Risk | 1 |
| Payout Ratio | 0.0 |
| Peg Ratio | 2.88 |
| Phone | 770 651 9100 |
| Post Market Change | -0.004999876 |
| Post Market Change Percent | -0.14640926 |
| Post Market Price | 3.41 |
| Post Market Time | 1,776,466,911 |
| Previous Close | 3.43 |
| Price Eps Current Year | 80.352936 |
| Price Hint | 4 |
| Price To Book | 1.971709 |
| Price To Sales Trailing12 Months | 1.2119411 |
| Profit Margins | 0.11604 |
| Quick Ratio | 3.763 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.16667 |
| Region | US |
| Regular Market Change | -0.0150001 |
| Regular Market Change Percent | -0.437321 |
| Regular Market Day High | 3.6 |
| Regular Market Day Low | 3.385 |
| Regular Market Day Range | 3.385 - 3.6 |
| Regular Market Open | 3.49 |
| Regular Market Previous Close | 3.43 |
| Regular Market Price | 3.415 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 2,007,856 |
| Return On Assets | 0.13166 |
| Return On Equity | 0.21607 |
| Revenue Growth | 0.271 |
| Revenue Per Share | 2.833 |
| Sand P52 Week Change | 0.36506534 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 1 |
| Shares Outstanding | 148,566,586 |
| Shares Percent Shares Out | 0.051599998 |
| Shares Short | 7,668,857 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 6,709,725 |
| Short Name | MiMedx Group, Inc |
| Short Percent Of Float | 0.0646 |
| Short Ratio | 7.32 |
| Source Interval | 15 |
| State | GA |
| Symbol | MDXG |
| Target High Price | 10.0 |
| Target Low Price | 6.0 |
| Target Mean Price | 8.8 |
| Target Median Price | 10.0 |
| Total Cash | 166,120,992 |
| Total Cash Per Share | 1.118 |
| Total Debt | 22,532,000 |
| Total Revenue | 418,630,016 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.32 |
| Trailing P E | 10.671875 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 6.2166 |
| Two Hundred Day Average Change | -2.8016 |
| Two Hundred Day Average Change Percent | -0.45066434 |
| Type Disp | Equity |
| Volume | 2,007,856 |
| Website | https://www.mimedx.com |
| Zip | 30,062 |